Rameda
Rameda, officially known as Rameda Pharmaceuticals, is a prominent player in the pharmaceutical industry, headquartered in Egypt (EG). Established in 1994, the company has made significant strides in the development and manufacturing of a diverse range of pharmaceutical products, including prescription medications, over-the-counter drugs, and dietary supplements. With a strong operational presence across the Middle East and North Africa, Rameda is recognised for its commitment to quality and innovation. The company’s core offerings include unique formulations that cater to various therapeutic areas, setting them apart in a competitive market. Rameda has achieved notable milestones, including regulatory approvals and partnerships that enhance its market position, solidifying its reputation as a trusted name in healthcare.
DitchCarbon Score
How does Rameda's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Rameda's score of 22 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Rameda's reported carbon emissions
Rameda, headquartered in Egypt (EG), currently does not report any specific carbon emissions data, as there are no available figures for kg CO2e emissions. Additionally, the company has not established any documented reduction targets or climate pledges. As of now, Rameda does not inherit emissions data from any parent or related organizations, indicating that their climate commitments and emissions reporting are independent. Without specific emissions data or reduction initiatives, it is unclear how Rameda is addressing climate change within the pharmaceutical industry context. The absence of reported emissions and targets suggests an opportunity for Rameda to enhance its sustainability efforts and align with industry standards for climate action.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Rameda is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
